|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/06 | |
| A61K 31/454 | |||
| A61P 5/06 |
| (11) | Patento numeris | 1768976 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05766869.1 |
| Europos patento paraiškos padavimo data | 2005-06-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-04-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/022408 |
| Data | 2005-06-22 |
| (87) | Numeris | WO 2006/016995 |
| Data | 2006-02-16 |
| (30) | Numeris | Data | Šalis |
| 583757 P | 2004-06-29 | US |
| (72) |
LORIMER, Keith, US
PINES, Seemon, H., US
PAUL, Bernhard, US
LITTER, Benjamin, US
|
| (73) |
Helsinn Healthcare S.A.,
Via Pian Scairolo, 9, 6912 Lugano / Pazzallo,
CH
|
| (54) | CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE |
| CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE |